FECAL CALPROTECTIN, PMN-ELASTASE AND ELASTASE-1 AS MARKERS OF ENTERAL DYSFUNCTION IN FULL-TERM NEONATES WITH PERINATAL PATHOLOGY

Authors

  • О. V. Kuryk Bukovinian State Medical University, Municipal Non-Profit Institution «Chernivtsi Regional Perinatal Center»
  • А. G. Babintseva Bukovinian State Medical University https://orcid.org/0000-0002-3859-6431

DOI:

https://doi.org/10.11603/24116-4944.2024.2.15088

Keywords:

neonate, perinatal pathology, enteral insufficiency, fecal markers, calprotectin, PMN-elastase, elastase-1

Abstract

The aim of the study – to determine dynamic changes in the levels of the fecal markers of enteral dysfunction (calprotectin, PMN-elastase, elastase-1) in full-term neonates with perinatal pathology during early neonatal period.

Materials and Methods. A comprehensive clinical-paraclinical examination of 205 full-term neonates was conducted. 82 of the infants presented the signs of severe perinatal pathology (group I) and 73 infants – moderate perinatal pathology (group II). 50 healthy full-term neonates were in the control group (group III). The study was carried out on the base of the Municipal Non-Profit Institution «Municipal Clinical Maternity Home № 2» of Chernivtsi Municipal Council, and German-Ukrainian laboratory «Bukintermed» (Chernivtsi). The licensed program Statistica (StatSoft Inc., Version 7.0) was used for statistical data analysis. The study was conducted following the «Rules of Ethical Principles of Conducting Scientific Medical Research with Human Participation», approved by the Declaration of Helsinki (1964–2013), ICH GCP (1996), EU Directives No. 609 dated 24.11.1986, the Order of the Ministry of Health of Ukraine No. 690 dated 23.09.2009, and the conclusion of the Biomedical Ethics Board of Bukovinian State Medical University.

Results and Discussion. The studied groups were similar according to their gestational age and anthropometric parameters at birth, and gender characteristics. During the first week of life, the level of calprotectin in infants from group I increased from (162.5±8.1) to (264.17±10.1) mcg/g (р<0.0001), in group II – from (296.2±11.2) to (388.9±12.4) mcg/g (р<0.0001), and in infants from group III it decreased from (423.3±20.06) to (260.1±12.4) mcg/g (р<0.0001). The highest level of this marker in the meconium was found in healthy neonates, while in infants with the signs of moderate perinatal pathology – in feces on the seventh day of their lives.During the first seven days of life, PMN-elastase levels in infants from group I decreased from (345.3±15.8) to (100.9±4.71) ng/g  (р<0.0001), in group II – from (300.4±15.0) to (45.5±1.84) ng/g (р<0.0001), and in infants from group III – from (463.3±17.3) to (132.8±6.4) ng/g (р<0.0001). The highest level of this enzyme was found in healthy neonates both in meconium and in feces on the seventh day of their lives. The level of fecal elastase-1 during the early neonatal period in infants from group I increased from (214.7±10.1) to (326.4±15.6) mcg/g (р<0.0001), in group II – from (134.9±6.18) to (221.6±11.0) mcg/g (р<0.0001), and in infants from group III – from (133.4±6.98) to (189.4±9.01) mcg/g (р<0.0001). The highest level of this marker was found in meconium and in feces on the seventh day of lives in infants with severe perinatal pathology.

Conclusions. Results of the study were indicative of a multidirectional dynamics in the levels of enteral dysfunction fecal markers during the early neonatal period in both healthy neonates and infants with different degree of perinatal pathology. The results obtained expand scientific knowledge concerning reference values of these markers in neonates and the role they play in physiological adjustment of the intestines to the conditions of extra-uterine life, as well as in diagnostics of enteral dysfunction with underlying perinatal pathology.

Author Biographies

О. V. Kuryk, Bukovinian State Medical University, Municipal Non-Profit Institution «Chernivtsi Regional Perinatal Center»

Chief of Neonatal Intensive Care Unit, Municipal Non-Profit Institution «Chernivtsi Regional Perinatal Center»

А. G. Babintseva, Bukovinian State Medical University

Doctor of Medicine, Full Professor, Professor of the Department of Pediatrics, Neonatology and Perinatal Medicine

Researcher ID: http://www.researcherid.com/rid/GLR-5882-2022

ScopusAuthor ID: https://www.scopus.com/authid/detail.uri?authorId=57201633922

References

Demirel, N., Unal, S., Durukan, M., Celik, I. H., Bas, A. I. (2023). Multi-organ dysfunction in infants with acidosis at birth in the absence of moderate to severe hypoxic ischemic encephalopathy. Early Human Development, 181, 105775. DOI: 10.1016/j.earlhumdev.2023.105775. DOI: https://doi.org/10.1016/j.earlhumdev.2023.105775

Shkurupii, D., Mohylnyk, A., Sonnyk, Ye. (2019). Porivnialno-vikova kharakterystyka stanu neirovehetatyvnoi rehuliatsii shlunkovo-kyshkovoho traktu u khvorykh v umovakh intensyvnoi terapii [Comparative-age characteristics of the state of the neurovegative regulation of the gastrointestinal tract in intensive care patients]. Aktualni problemy suchasnoi medytsyny - Actual problems of modern medicine, 19(3), 100–103. DOI: 10.31718/2077-1096.19.3.100 [in Ukrainian]. DOI: https://doi.org/10.31718/2077-1096.19.3.100

Castanet, M., Costalos, C., Haiden, N., Hascoet, J-M., Berger, B., Sprenger, N., Grathwohl, D., Brüssow, H., De Groot, N., Steenhout, P. (2020). Early effect of supplemented infant formulae on intestinal biomarkers and microbiota: a randomized clinical trial. Nutrients. 12(5), 1481. DOI: 10.3390/nu12051481. DOI: https://doi.org/10.3390/nu12051481

Godovanets, O., Nechytailo, Yu. (2024). Klinichna kharakterystyka ta mozhlyvosti laboratornoi diahnostyky hastrointestynalnykh porushen pry perynatalnii patolohii u peredchasno narodzhenykh ditei [Clinical characteristics and possibilities of laboratory diagnostics of gastrointestinal diseases in perinatal pathology of premature infants]. Neonatolohiia, khirurhiia ta perynatalna medytsyna - Neonatology, surgery and perinatal medicine, 2(52), 28–33. DOI: 10.24061/2413-4260.XIV.2.52.2024.5. [in Ukrainian]. DOI: https://doi.org/10.24061/2413-4260.XIV.2.52.2024.5

Matara, D-I., Pouliakis, A., Xanthos, T., Sokou, R., Kafalidis, G., Iliodromiti, Z., Boutsikou, T., Iacovidou, N., Salakos, C. (2022). Microbial translocation and perinatal asphyxia/hypoxia: a systematic review. Diagnostics, 12(1), 214. DOI: 10.3390/diagnostics12010214. DOI: https://doi.org/10.3390/diagnostics12010214

Klinke, M., Chaaban, H., Boettcher, M. (2023). The role of neutrophil extracellular traps in necrotizing enterocolitis. Front. Pediatr., 11. DOI: 10.3389/fped.2023.1121193. DOI: https://doi.org/10.3389/fped.2023.1121193

Peterslund, P., Rasmussen, L, Qvist, N., Hansen, T. P., Husby, S., Detlefsen, S. (2019). Frequencies of immune cells in the human small bowel during normal gestation and in necrotizing enterocolitis. Fetal. Pediatr. Pathol., 38, 153–166. DOI: 10.1080/15513815.2018.1561774. DOI: https://doi.org/10.1080/15513815.2018.1561774

D’Amico, F., Nancey, S., Danese, S., Peyrin-Biroulet, L. (2021). A practical guide for faecal calprotectin measurement: myths and realities. Journal of Crohn's and Colitis, 15(1), 152–161. DOI: 10.1093/ecco-jcc/jjaa093. DOI: https://doi.org/10.1093/ecco-jcc/jjaa093

Parc, J.S., Cho, J.Y., Chung, C., Oh, S.H., Do, H-j (2020). Dynamic changes of fecal calprotectin and related clinical factors in neonates. Front. Pediatr, 8. DOI: 10.3389/fped.2020.00326. DOI: https://doi.org/10.3389/fped.2020.00326

Paysal, J., Oris, C., Troin, U., Limeri, P-N., Allard, J., Tadrent, M., Pereira, B., Merlin, E., Rochette, E., Evrard, B. (2023). Influence of perinatal factors on blood tryptase and fecal calprotectin levels in newborns. Children, 10(2), 345. DOI: 10.3390/children10020345. DOI: https://doi.org/10.3390/children10020345

Lężyk-Ciemniak, E., Tworkiewicz, M., Wilczyńska, D., Szaflarska-Popławska, A., Krogulska, A. (2021). Usefulness of testing for fecal calprotectin in pediatric gastroenterology clinical practice. Med Princ Pract., 30(4), 311–319. DOI: 10.1159/000512631. DOI: https://doi.org/10.1159/000512631

Kaczmarczyk, M., Löber, U., Adamek, K., Węgrzyn, D., Skonieczna-Żydecka, K., Malinowski, D., Łoniewski, I., Markó, L., Ulas, T., Forslund, S.K., et al. (2021). The gut microbiota is associated with the small intestinal paracellular permeability and the development of the immune system in healthy children during the first two years of life. J. Transl. Med., 19, 177. DOI: 10.21203/rs.3.rs-154335/v1. DOI: https://doi.org/10.1186/s12967-021-02839-w

Rodríguez-Belvís, M.V., Bris, J.F.V., Fernández, C.P., García-Salido, A., Antón, J.A., Ortega, G.D., Codoceo, R.A.M. (2020). Normal fecal calprotectin levels in healthy children are higher than in adults and decrease with age. Paediatrics & Child Health, 25(5), 286–292. DOI: 10.1093/pch/pxz070. DOI: https://doi.org/10.1093/pch/pxz070

Campeotto, F., Elie, C., Rousseau, C., Giuseppi, A., Hachem, T., Gobalakichenane, P., Le Touzey, M., de Stefano, M., Butel, M., Kapel, N. (2021). Faecal calprotectin and gut microbiota do not predict enteropathy in very preterm infants. Acta Paediatr., 110, 109–116. DOI: 10.1093/pch/pxz070. DOI: https://doi.org/10.1111/apa.15354

Cekovic, J., Prodanovic, N., Mijailovic, S., Knezevic, S., Vuletic, B., Stojkovic, A., Savic, D., Prodanovic, T., Stanojevic, M. & Simovic, A. (2022). The perinatal factors that influence the excretion of fecal calprotectin in premature-born children. Open Medicine, 17(1), 1275-1281. DOI: 10.1515/med-2022-0522. DOI: https://doi.org/10.1515/med-2022-0522

Ramos, A.D.S., Viana, G.S.C., Brigido, M.de M., Almeida, J.F. (2021). Neutrophil extracellular traps in inflammatory bowel diseases: implications in pathogenesis and therapeutic targets. Pharmacological Research, 171, 105779, DOI: 10.1016/j.phrs.2021.105779. DOI: https://doi.org/10.1016/j.phrs.2021.105779

Drury, B., Hardisty, G., Gray, R.D., Ho, G. (2021). Neutrophil extracellular traps in inflammatory bowel disease: pathogenic mechanisms and clinical translation. Cellular and Molecular Gastroenterology and Hepatology, 12(1), 321–333. DOI: 10.1016/j.jcmgh.2021.03.002. DOI: https://doi.org/10.1016/j.jcmgh.2021.03.002

Lisowska-Myjak, B., Skarżyńska, E., Jakimiuk, A.J. (2023). Links between vitamin D-binding protein, alpha-1 antitrypsin and neutrophil proteins in meconium. Cellular Physiology and Biochemistry, 57, 15–22. DOI: 10.33594/000000604. DOI: https://doi.org/10.33594/000000604

Jenkinson, A., Aladangady, N., Wellmann, S., Eaton, S., Bührer, C., Fleming, P., Roehr, C. (2024). Pancreatic insufficiency, digestive enzyme supplementation, and postnatal growth in preterm babies. Neonatology. 121(3), 283–287. DOI: 10.33594/000000604. DOI: https://doi.org/10.1159/000535964

Jones, A.M. (2023). The clinical and laboratory impact of reporting faecal elastase-1 in watery stool samples. Annals of Clinical Biochemistry, 60(1), 72–74. DOI: 10.1177/00045632221143678. DOI: https://doi.org/10.1177/00045632221143678

Münch, A., Bührer, C., Longardt, A.C. (2021). Digestive enzyme replacement relieves growth failure in preterm infants with poor exocrine pancreatic function: a retrospective case series. Eur J Pediatr, 180, 2951–2958. DOI: 10.1007/s00431-021-04069-0. DOI: https://doi.org/10.1007/s00431-021-04069-0

Published

2025-01-22

How to Cite

Kuryk О. V., & Babintseva А. G. (2025). FECAL CALPROTECTIN, PMN-ELASTASE AND ELASTASE-1 AS MARKERS OF ENTERAL DYSFUNCTION IN FULL-TERM NEONATES WITH PERINATAL PATHOLOGY. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 80–87. https://doi.org/10.11603/24116-4944.2024.2.15088

Issue

Section

PEDIATRICS